Syneron Medical Ltd

Type: Company
Name: Syneron Medical Ltd
First reported Aug 21 2014 - Updated Aug 21 2014 - 1 reports

Syneron Medical Introduces New FDA-Cleared 5mm Spot Size for Treatment of Onychomycosis

By a News Reporter-Staff News Editor at Pharma Business Week -- Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, announced the market launch of its proprietary handpiece featuring a new 5-millimeter spot size for the Gentle ... [Published 4 Traders - Aug 21 2014]
First reported Aug 20 2014 - Updated Aug 20 2014 - 1 reports

Syneron Medical Has Returned 10.9% Since SmarTrend Recommendation (ELOS)

SmarTrend identified a Downtrend for Syneron Medical (NASDAQ:ELOS) on April 11th, 2014 at $11.20. In approximately 4 months, Syneron Medical has returned 10.89% as of today's recent price of $9.98. ... [Published Individual.com - Aug 20 2014]
First reported Aug 15 2014 - Updated Aug 15 2014 - 1 reports

Syneron Medical (ELOS) Trading Near $10.60 Resistance Level

The patented option trade-picking algorithms behind MarketIntelligenceCenter.com's Artificial Intelligence Center have selected a covered call trade on Syneron Medical (http://www.marketintelligencecenter.com/symbol/ELOS"ELOS) that includes 9.88% downside ... [Published Individual.com - Aug 15 2014]
First reported Aug 14 2014 - Updated Aug 15 2014 - 4 reports

Syneron Medical launches 5mm spot size handpiece to treat nail fungus

Aesthetic device company Syneron Medical has introduced new FDA-cleared handpiece to treat onychomycosis (nail fungus).Featuring a new 5mm spot size for the Gentle Pro Nd:YAG Laser Series, the device expands the functionality of the GentleYAG Pro and ... [Published Medical Devices Business Review - Aug 15 2014]
First reported Aug 14 2014 - Updated Aug 14 2014 - 2 reports

Update: Syneron Medical Earnings

By Andy Batts :Syneron Medical (NASDAQ: ELOS ) reported net income of $2.5 million and EPS of $0.07 in the second quarter of 2014, compared to net income of $3 million, or $0.08 per share in the second quarter of 2013. Revenue in the quarter came in at ... [Published BioPortfolio - Aug 14 2014]
First reported Aug 12 2014 - Updated Aug 13 2014 - 2 reports

Syneron Medical Shares Down 12.1% Since SmarTrend's Sell Call (ELOS)

Written on Tue, 08/12/2014 - 6:27pmBy Nick RussoSmarTrend identified a Downtrend for Syneron Medical ( NASDAQ:ELOS ) on April 11th, 2014 at $11.20. In approximately 4 months, Syneron Medical has returned 12.05% as of today's recent price of $9.85.Syneron ... [Published Comtex SmarTrend - Aug 13 2014]
First reported Aug 06 2014 - Updated Aug 06 2014 - 2 reports

Syneron Medical's (ELOS) CEO Amit Meridor on Q2 2014 Results - Earnings Call Transcript

OperatorGood day, ladies and gentlemen, and welcome to the Syneron Medical Ltd. Q2 2014 Results Conference Call. Today’s conference is being recorded. (Operator Instructions)At this time, I’d like to turn the conference over to Zack Kubow. Please go ahead ... [Published Seeking Alpha - Aug 06 2014]
First reported Aug 06 2014 - Updated Aug 06 2014 - 1 reports

Syneron Medical Q2 non-GAAP shr $0.07

(Corrects to remove extraneous text from headline)Aug 6 (Reuters) - Aug 6 (Reuters) - Syneron Medical Ltd : * Q2 NON-GAAP SHR $0.07; Q2 REVENUE $64.6 MLN * Q2 shr view $0.07 -- thomson reuters I/B/E/S * Q2 earnings per share view $0.07, revenue view $63.5 ... [Published Yahoo! Finance - Aug 06 2014]
First reported Jul 30 2014 - Updated Jul 30 2014 - 1 reports

Syneron Medical Schedules Release of Second Quarter 2014 Financial Results

Syneron Medical said that it will release second quarter 2014 financial results before the market opens on Wednesday, August 6 .According to a release from the company, the earnings release will be available on Syneron's website.Syneron noted its management ... [Published 4 Traders - Jul 30 2014]
First reported Jul 29 2014 - Updated Jul 29 2014 - 1 reports

Downtrend Call Working As Syneron Medical Stock Falls 12.1% (ELOS)

Written on Tue, 07/29/2014 - 12:04pmBy Shiri GuptaSmarTrend identified a Downtrend for Syneron Medical ( NASDAQ:ELOS ) on April 11th, 2014 at $11.20. In approximately 4 months, Syneron Medical has returned 12.14% as of today's recent price of $9.84.Syneron ... [Published Comtex SmarTrend - Jul 29 2014]
First reported Jul 28 2014 - Updated Jul 28 2014 - 2 reports

Syneron Medical Ltd announces CE mark for PicoWay Dual Wavelength Picosecond Laser for tattoo removal and treatment of pigmented lesions

Syneron Medical Ltd:Says its new PicoWay device has received CE Mark indication to treat tattoos of all types and colors and pigmented lesions on any skin type.PicoWay is new and innovative dual wavelength device, with 532nm and 1064nm wavelengths, which ... [Published Reuters - Jul 28 2014]
First reported Jul 25 2014 - Updated Jul 26 2014 - 3 reports

Syneron Medical to host investor meeting to highlight opportunities in body contouring/fat treatment market

Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, announced today that it will host an investor meeting on Wednesday, September 17, 2014, at approximately 10:00 am to 1:00 pm ET in New York City. The meeting will highlight ... [Published News-Medical.Net - Jul 26 2014]

Quotes

...technological advancements designed to meet and surpass our physician partners' standards," said Amit Meridor , Chief Executive Officer of Syneron . "The 5 mm handpiece makes our Gentle Pro laser even more valuable for our customers, expanding patient services with one simple addition."
"With UltraShape, we are pleased to offer our patients non-surgical liposuction-like results. UltraShape is an amazing and innovative technology in that it uses gentle, focused ultrasound to kill fat cells without damaging the skin or causing pain. And best of all, there is no downtime for this fat destroying therapy,” comments Dr. Bassichis. “Most of the other fat burning lasers cause treatment discomfort, however UltraShape is painlessly effective. After just three treatments, given every two weeks for six weeks, our patients experience a circumferential reduction in fat" says Dr. Bassichis
...com's Artificial Intelligence Center have selected a covered call trade on Syneron Medical (http://www.marketintelligencecenter.com/symbol/ELOS "ELOS) that includes 9.88% downside protection. Sell one contract of the Mar. '15 $10.00 call for every 100 shares of ELOS for a net debit per share of about $9.12. If Syneron Medical closes at or above $10.00 at expiration, this trade will return 9.65% or 16.23% annualized. Support has been above $9.20 while resistance has been below $10.60. ELOS closed at $10.12 after trading between $9.44 and $10.14 Thursday."
...The fund continues to hold well over a quarter of the AUM in cash. Seth Klarman's distinct investment style is elaborated in his 1991 book " Margin of Safety: Risk-averse value investing strategies for the thoughtful investor ": the book is out-of-print and copies sell for a huge premium."

More Content

All (76) | News (46) | Reports (0) | Blogs (23) | Audio/Video (0) | Fact Sheets (1) | Press Releases (6)
sort by: Date | Relevance
Syneron Medical Introduces New FDA-Cleared 5mm ... [Published 4 Traders - Aug 21 2014]
Syneron Medical Has Returned 10.9% Since SmarTr... [Published Individual.com - Aug 20 2014]
World Skincare Devices Market Is Expected To Re... [Published BioSpace - Aug 20 2014]
Dallas Plastic Surgeon Dr. Benjamin Bassichis i... [Published PRWeb - Aug 19 2014]
Syneron Medical (ELOS) Showing Bearish Technica... [Published MarketIntelligenceCenter.com - Aug 19 2014]
Syneron Medical (ELOS) Trading Near $10.25 Resi... [Published MarketIntelligenceCenter.com - Aug 18 2014]
Syneron launches new 5-mm spot size onychomycos... [Published Orthopedics Today - Aug 15 2014]
Syneron Medical (ELOS) Trading Near $10.60 Resi... [Published Individual.com - Aug 15 2014]
Syneron Medical launches 5mm spot size handpiec... [Published Medical Devices Business Review - Aug 15 2014]
Tracking Seth Klarman's Baupost Group Holdings ... [Published Seeking Alpha - Aug 15 2014]
Syneron Medical (ELOS) Trading Near $10.60 Resi... [Published MarketIntelligenceCenter.com - Aug 15 2014]
United States Aesthetic Lasers and Energy Devic... [Published Individual.com - Aug 15 2014]
LGND Does A Deal, Q2 Revenue A Bitter Pill For ... [Published RTTNews.com - Aug 15 2014]
Klarman's Baupost Group 13F Shows New Stakes in... [Published Industrial Info Financials - Aug 14 2014]
Update: Syneron Medical Earnings [Published BioPortfolio - Aug 14 2014]
Researchers Submit Patent Application, "Method ... [Published 4 Traders - Aug 14 2014]
Update: Syneron Medical Earnings [Published Seeking Alpha - Aug 14 2014]
Syneron Medical Introduces New FDA-Cleared 5mm ... [Published Bio-Medicine - Aug 14 2014]
Syneron Medical Introduces New FDA-Cleared 5mm ... [Published TickerTech.com - Aug 14 2014]
Syneron Medical Introduces New FDA-Cleared 5mm ... [Published PR Newswire: Consumer Products & Retail - Aug 14 2014]
Aesthetic Equipment Market - Industry Analysis,... [Published MyNewsDesk - Aug 13 2014]
Syneron Medical Shares Down 12.1% Since SmarTre... [Published Comtex SmarTrend - Aug 13 2014]
Syneron Medical Shares Down 12.1% Since SmarTre... [Published Individual.com - Aug 12 2014]
Syneron dual-wavelength picosecond laser receiv... [Published OptoIQ - Aug 11 2014]
Syneron Medical's (ELOS) CEO Amit Meridor on Q2... [Published Seeking Alpha - Aug 06 2014]
Sector Update: Health Care Shares Lower Pre-Market [Published Nasdaq - Aug 06 2014]
More on Syneron Med Q2 results [Published Seeking Alpha - Aug 06 2014]
Syneron Medical Q2 non-GAAP shr $0.07 [Published Yahoo! Finance - Aug 06 2014]
Syneron Reports Second Quarter 2014 Results [Published TickerTech.com - Aug 06 2014]
Syneron Reports Second Quarter 2014 Results [Published PR Newswire: Financial Services - Aug 06 2014]
1 2 3
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Syneron Medical (ELOS) Showing Bearish Technica... [Published MarketIntelligenceCenter.com - Aug 19 2014]
Option-trade picking algorithms patented by MarketIntelligenceCenter.com found a trading opportunity with Syneron Medical (ELOS) that should provide a 10.50% return in just 213 days. Sell one Mar. '15 call at the $10.00 level for each 100 shares of Syneron ...
Syneron Medical (ELOS) Trading Near $10.25 Resi... [Published MarketIntelligenceCenter.com - Aug 18 2014]
The patented option trade-picking algorithms behind MarketIntelligenceCenter.com's Artificial Intelligence Center have selected a covered call trade on Syneron Medical (ELOS) that includes 9.86% downside protection. Sell one contract of the Mar. '15 $10.00 ...
Syneron Medical (ELOS) Trading Near $10.60 Resi... [Published MarketIntelligenceCenter.com - Aug 15 2014]
The patented option trade-picking algorithms behind MarketIntelligenceCenter.com's Artificial Intelligence Center have selected a covered call trade on Syneron Medical (ELOS) that includes 9.88% downside protection. Sell one contract of the Mar. '15 $10.00 ...
Syneron Medical Introduces New FDA-Cleared 5mm ... [Published PR Newswire: Consumer Products & Retail - Aug 14 2014]
IRVINE, Calif., Aug. 14, 2014 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, announced today the market launch of its proprietary handpiece featuring a new 5-millimeter spot size for the Gentle Pro ...
Syneron Reports Second Quarter 2014 Results [Published PR Newswire: Financial Services - Aug 06 2014]
YOKNEAM, Israel, Aug. 6, 2014 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today announced financial results for the three month period ended June 30, 2014. Second Quarter 2014[1] and Second Quarter ...
1 2 3 4 5

Press Releases

sort by: Date | Relevance
Syneron Reports Second Quarter 2014 Results [Published Financial Services - Aug 06 2014]
Syneron Reports First Quarter 2014 Results [Published Financial Services - May 14 2014]
Syneron Receives US FDA Clearance to Market the... [Published Financial Services - Apr 14 2014]
Syneron's Innovative Products Featured at 34th ... [Published Financial Services - Apr 04 2014]
Syneron Sublative Technology Earns CE Mark for ... [Published Financial Services - Apr 03 2014]
1 2
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.